Oncodesign Company
%20.jpg)
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Technology:
Precision Medicine
Headquarters:
Others
Funding Status:
IPO
Founded Date:
1995-01-01
Last Funding Type:
Venture - Series Unknown
Investors Number:
3
Estimated Revenue:
$1M to $10M
Employee Number:
101-250
Total Funding:
$29.4M
Industry:
P4 Medicine
Investor Type:
For Profit